In vitro efficacy of six alternative antibiotics against multidrug resistant escherichia coli and Klebsiella pneumoniae from urinary tract infections

Annals of the Academy of Medicine Singapore

Volumn 45, Issue 6, 2016, Pages 245-250

  Chen, Yu Ting ^a   Murad, Katzrin Ahmad ^a   Ng, Lily S Y ^b   Seah, Jonathan T H ^b   Park, Joon Jae ^b   Tan, Thean Yen ^b  

^a DEPARTMENT OF ELECTRONICS AND COMPUTER ENGINEERING   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Ceftibuten; Extended spectrum beta lactamases; Fosfomycin; Temocillin

Indexed keywords

AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CEFPODOXIME; CEFTIBUTEN; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; FOSFOMYCIN; MECILLINAM; PENICILLIN DERIVATIVE; TEMOCILLIN; TRIMETHOPRIM;

ANALOGS AND DERIVATIVES; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; GENOTYPE; HUMAN; IN VITRO STUDY; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; SINGAPORE; URINARY TRACT INFECTION;

AMDINOCILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTIZOXIME; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FOSFOMYCIN; GENOTYPE; HUMANS; IN VITRO TECHNIQUES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; PENICILLINS; SINGAPORE; TRIMETHOPRIM; URINARY TRACT INFECTIONS;

EID: 85012844158     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-20.
2. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-23.
3. Bahadin J, Teo SSH, Mathew S. Aetiology of community-acquired urinary tract infection and antimicrobial susceptibility patterns of uropathogens isolated. Singapore Med J 2011;52:415-20.
4. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement. CLSI document M100-S23. Wayne, PA: Clinical Laboratory Standards Institute; 2013.
5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
6. Tan TY, Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 2009;53:146-9.
7. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing. Version 12 May 2013: British Society for Antimicrobial Chemotherapy;2013. Available at: http://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final.pdf. Accessed on 27 July 2014.
8. Monstein HJ, Ostholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, Nilsson LE. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 2007;115:1400-8.
9. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62.
10. Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonça R, Nonhoff C, Struelens MJ. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother 2006;57:771-4.
11. Thulin E, Sundqvist M, Andersson DI. Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob Agents Chemother 2015;59:1718-27.
12. Moore CE, Sona S, Poda S, Putchhat H, Kumar V, Sopheary S, et al. Antimicrobial susceptibility of uropathogens isolated from Cambodian children. Paediatr Int Child Health. 2015:2046905515Y0000000008.
13. Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010;65:1862-77.
14. Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, et al. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 2011;66:2628-31.
15. Ho MW, Wang FD, Fung CP, Liu CY. Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections. J Microbiol Immunol Infect 2001;34:185-9.
16. Neuhaus TJ, Berger C, Buechner K, Parvex P, Bischoff G, Goetschel P, et al. Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr 2008;167:1037-47.
17. Bjerrum L, Gahrn-Hansen B, Grinsted P. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial. Scand J Prim Health Care 2009;27:6-11.
18. Soraas A, Sundsfjord A, Jorgensen SB, Liestol K, Jenum PA. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. PLoS One 2014;9:e85889.